Are Options Traders Bullish on AUPH?
Let daily Option Order Flow show you where stock investors are Bullish and Bearish!!! Receive a FREE daily email of the Market Chameleon Order Flow Sentiment Newsletter.
Market Chameleon

About AUPH

Aurinia is a clinical stage pharmaceutical company focused on the global nephrology market. It is currently in the recruitment and enrollment phase of its Phase 2b clinical trial to evaluate the efficacy of its drug, voclosporin, as a treatment for lupus nephritis (LN). LN is an inflammation of the kidneys, that if inadequately treated can lead to end-stage renal disease, making LN a serious and potentially life-threatening condition.
Primary Exchange: NASDAQ
SIC
NAICS Pharmaceutical Preparation Manufacturing

AUPH is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 250.8 M 2.50848E+08 234 234 0.03% 0.000291531 165 K 165140
IBB iShares Nasdaq Biotechnology Index Fund 8.0 B 8.01514E+09 223 223 0.09% 0.0009 7.1 M 7055540
UBIO Proshares UltraPro Nasdaq Biotechnology 32.6 M 3.26377E+07 228 228 0.02% 0.000181099 20 K 19747

Wait, Before You Leave...